Lung cancer – Tiragolumab Plus Atezolizumab Survival
Overview Lung cancer is a very challenging condition to manage, especially when discovered late. The incredibly high incidence of lung cancer – mostly caused by smoking tobacco products – made…
Overview Lung cancer is a very challenging condition to manage, especially when discovered late. The incredibly high incidence of lung cancer – mostly caused by smoking tobacco products – made…
Overview The spread of cancer cells beyond the original site of the tumor is a very challenging process. When cancer cells of the breast are found somewhere distant (e.g., the…
Overview Glioblastoma, or GBM, is an aggressive type of tumor that occurs in the brain. Due to the location of this tumor and the limited therapeutic options, patients often have…
Overview Ever since their discovery, advanced cases of cholangiocarcinoma and gallbladder cancers have been a big issue for doctors to manage. Since these cancers only present with symptoms when the…
Overview Over the past few years, researchers have been trying to find new treatment protocols for colorectal cancer by combining anticancer drugs. Fortunately, these efforts seem to be yielding some…
Overview The FDA has granted a Fast Track Designation to the novel MDM2-p53 inhibitor named “Alrizomadlin” (APG-115) for the treatment of patients with unresectable or metastatic melanoma that is either…
Overview Based on its potential to prolong overall survival in patients with Glioblastoma, GBM, Berubicin was granted Fast Track Designation by the American Food and Drug Administration, the FDA, for…
About the FDA decision in Cervical Cancer The Food and Drug Administration, the FDA, has granted an accelerated approval to Tivdak (Tisotumab Vedotin-tftv) for the treatment of patients with recurrent…
Overview Nasopharyngeal carcinoma is a malignant tumor that affects the head and neck. Typically, this cancer starts in the upper part of the throat and spreads from there. Unfortunately, metastatic…
He is our client, a charming 58 year old man and has colorectal cancer with liver metastases. He received the standard protocol until he reached out to us and then…